The major finding is the CV benefit. Fibrates seem to be much more potent in people with kidney disease, and this is important. Thus, overall, the results suggest that fibrates could be used more ...
This review paper summarizes numerous research studies that address the role of kidney cholesterol and lipid accumulation in the development and progression of chronic kidney disease (CKD). ZyVersa’s ...
The joint document, published simultaneously in the journals JACC and Circulation, addresses not just cholesterol, but a full range of blood lipids that contribute to atherosclerosis — the buildup of ...
CHARLESTON, SC – Just last November, the American College of Cardiology (ACC) and American Heart Association (AHA) published new clinical guidelines for the management of cholesterol, and the ...
STOCKHOLM—New results suggest that combination therapy with ezetimibe/simvastatin, when prescribed at the recommended starting and next higher doses, is more likely to improve lipids than atorvastatin ...
The American College of Cardiology, the American Heart Association and nine other leading medical organizations have updated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results